quinazolines has been researched along with Incontinentia Pigmenti Achromians in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cáncela-Díez, B; Cuenca-Barrales, C; Galvez-Moreno, M; López-Delgado, D; Ruiz-Villaverde, R | 1 |
Robert, C; Sibaud, V | 1 |
Ishikawa, T; Kamide, R; Niimura, M | 1 |
1 review(s) available for quinazolines and Incontinentia Pigmenti Achromians
Article | Year |
---|---|
[Pigmentary disorders induced by anticancer agents. Part II: targeted therapies].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Cetuximab; Dasatinib; ErbB Receptors; Humans; Imatinib Mesylate; Indazoles; Indoles; Ipilimumab; Niacinamide; Phenylurea Compounds; Pigmentation Disorders; Piperazines; Piperidines; Programmed Cell Death 1 Receptor; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Quinazolines; Receptors, Vascular Endothelial Growth Factor; Sorafenib; Sulfonamides; Sunitinib; Thiazoles | 2013 |
2 other study(ies) available for quinazolines and Incontinentia Pigmenti Achromians
Article | Year |
---|---|
Gray-bluish cutaneous pigmentation and ice-pick scars induced by vandetanib therapy.
Topics: Adult; Antineoplastic Agents; Cicatrix; Color; Drug Eruptions; Facial Dermatoses; Female; Humans; Pigmentation Disorders; Piperidines; Quinazolines | 2018 |
Photoleukomelanodermatitis (Kobori) induced by afloqualone.
Topics: Aged; Drug Eruptions; Humans; Male; Muscle Relaxants, Central; Photosensitivity Disorders; Pigmentation Disorders; Quinazolines | 1994 |